- Home
- XERS vs HLF Comparison
XERS vs HLF Comparison
Compare XERS & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- HLF
- Stock Information
- Founded
- XERS 2005
- HLF 1980
- Country
- XERS United States
- HLF United States
- Employees
- XERS 394
- HLF N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- HLF Other Pharmaceuticals
- Sector
- XERS Health Care
- HLF Health Care
- Exchange
- XERS Nasdaq
- HLF Nasdaq
- Market Cap
- XERS 1.3B
- HLF 854.5M
- IPO Year
- XERS 2018
- HLF N/A
- Fundamental
- Price
- XERS $7.93
- HLF $9.24
- Analyst Decision
- XERS Strong Buy
- HLF Strong Buy
- Analyst Count
- XERS 7
- HLF 4
- Target Price
- XERS $8.00
- HLF $11.50
- AVG Volume (30 Days)
- XERS 3.5M
- HLF 1.9M
- Earning Date
- XERS 08-07-2025
- HLF 08-06-2025
- Dividend Yield
- XERS N/A
- HLF N/A
- EPS Growth
- XERS N/A
- HLF 285.96
- EPS
- XERS N/A
- HLF 3.17
- Revenue
- XERS $246,025,000.00
- HLF $4,928,500,000.00
- Revenue This Year
- XERS $43.89
- HLF $0.40
- Revenue Next Year
- XERS $20.40
- HLF $4.25
- P/E Ratio
- XERS N/A
- HLF $2.97
- Revenue Growth
- XERS 35.62
- HLF N/A
- 52 Week Low
- XERS $2.48
- HLF $5.04
- 52 Week High
- XERS $8.02
- HLF $10.83
- Technical
- Relative Strength Index (RSI)
- XERS 80.36
- HLF 50.78
- Support Level
- XERS $7.27
- HLF $9.15
- Resistance Level
- XERS $8.02
- HLF $9.76
- Average True Range (ATR)
- XERS 0.32
- HLF 0.38
- MACD
- XERS 0.03
- HLF -0.01
- Stochastic Oscillator
- XERS 93.99
- HLF 55.56
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About HLF Herbalife Ltd.
Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management, targeted nutrition, Energy, Sports and Fitness, Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Latin America, EMEA, Asia Pacific regions, and China.